Daflon 450 mg+50 mg (Tablet)
Unit Price: ৳ 16.00 (2 x 15: ৳ 480.00)
Strip Price: ৳ 240.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Diosmin hesperidin |
| Company | Servier bangladesh operation |
| Also available as |
Indications
- Treatment of acute hemorrhoidal attacks
- Treatment of chronic hemorrhoidal disease
- Treatment of organic and functional chronic venous insufficiency of the lower limbs
- Relief of symptoms such as heavy legs, pain, and nocturnal cramps
Composition
- Each film coated tablet contains Diosmin micronised BP 450 mg
- Each film coated tablet contains Hesperidin micronised INN 50 mg
- Each DS film coated tablet contains Diosmin micronised BP 900 mg
- Each DS film coated tablet contains Hesperidin micronised USP 100 mg
Mode of Action
- Phlebotonic drug
- Vascular protecting agent
- Reinforces venous tone
- Decreases venous capacitance
- Decreases venous distensibility
- Decreases venous emptying time
- Protects the microcirculation
- Combats venous inflammation
- Decreases leukocyte activation
- Inhibits release of inflammatory mediators
- Normalizes capillary permeability
- Strengthens capillary resistance
- Improves lymphatic drainage
- Increases lymph flow
- Increases lymph oncotic pressure
Dosage
- Diosmin 450 mg & Hesperidin 50 mg: varying dosage for acute hemorrhoidal attacks, chronic hemorrhoids, and chronic venous insufficiency
- Diosmin 900 mg & Hesperidin 100 mg: varying dosage for acute hemorrhoidal attacks, relapse of internal hemorrhoid, chronic hemorrhoid, chronic venous insufficiency, and leg wounds
Administration
- Tablets should be taken at meal times
Interaction
- No evidence of drug incompatibility reported in clinical trials
Contraindications
- Contraindicated in individuals with hypersensitivity to any ingredient in the product
Side Effects
- Reported cases of routine gastric disorders
- Reported cases of neurovegetative disorders
Pregnancy & Lactation
- No teratogenic effect shown in animals
- No reported harmful effects in human beings
- Breast feeding not recommended during treatment due to lack of data on excretion into breast milk
Precautions & Warnings
- If hemorrhoidal symptoms do not disappear within 15 days, patient should consult a doctor
- Not recommended for patients with a history of cancer
- No evidence of carcinogenicity or mutagenicity found in animal studies and clinical use in Europe
Therapeutic Class
- Phlebotonic & Vascular protecting preparation
Storage Conditions
- Keep below 30°C temperature
- Keep away from light & moisture
- Keep out of the reach of children